These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 18624676)

  • 1. Species selection considerations for preclinical toxicology studies for biotherapeutics.
    Bussiere JL
    Expert Opin Drug Metab Toxicol; 2008 Jul; 4(7):871-7. PubMed ID: 18624676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternative strategies for toxicity testing of species-specific biopharmaceuticals.
    Bussiere JL; Martin P; Horner M; Couch J; Flaherty M; Andrews L; Beyer J; Horvath C
    Int J Toxicol; 2009; 28(3):230-53. PubMed ID: 19546261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Considerations regarding nonhuman primate use in safety assessment of biopharmaceuticals.
    Buckley LA; Chapman K; Burns-Naas LA; Todd MD; Martin PL; Lansita JA
    Int J Toxicol; 2011 Oct; 30(5):583-90. PubMed ID: 22013138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Considerations for the nonclinical safety evaluation of antibody drug conjugates for oncology.
    Roberts SA; Andrews PA; Blanset D; Flagella KM; Gorovits B; Lynch CM; Martin PL; Kramer-Stickland K; Thibault S; Warner G
    Regul Toxicol Pharmacol; 2013 Dec; 67(3):382-91. PubMed ID: 24012707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in selecting appropriate non-rodent species for regulatory toxicology research: Policy, ethical, and experimental considerations.
    Son YW; Choi HN; Che JH; Kang BC; Yun JW
    Regul Toxicol Pharmacol; 2020 Oct; 116():104757. PubMed ID: 32758521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety assessment of biotechnology-derived pharmaceuticals: ICH and beyond.
    Serabian MA; Pilaro AM
    Toxicol Pathol; 1999; 27(1):27-31. PubMed ID: 10367669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A critical evaluation of developmental and reproductive toxicology in nonhuman primates.
    Faqi AS
    Syst Biol Reprod Med; 2012 Feb; 58(1):23-32. PubMed ID: 22239078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small molecule immunomodulatory drugs: challenges and approaches for balancing efficacy with toxicity.
    Haley PJ
    Toxicol Pathol; 2012; 40(2):261-6. PubMed ID: 22083586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonhuman primates as animal models for toxicology research.
    Burbacher TM; Grant KS
    Curr Protoc Toxicol; 2001; Chapter 1():Unit1.1. PubMed ID: 23045019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical pharmacokinetics: an approach towards safer and efficacious drugs.
    Singh SS
    Curr Drug Metab; 2006 Feb; 7(2):165-82. PubMed ID: 16472106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical development strategies for novel gene therapeutic products.
    Pilaro AM; Serabian MA
    Toxicol Pathol; 1999; 27(1):4-7. PubMed ID: 10367665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scientific and Regulatory Policy Committee Points-to-consider Paper*: Drug-induced Vascular Injury Associated with Nonsmall Molecule Therapeutics in Preclinical Development: Part I. Biotherapeutics.
    Frazier KS; Engelhardt JA; Fant P; Guionaud S; Henry SP; Leach MW; Louden C; Scicchitano MS; Weaver JL; Zabka TS;
    Toxicol Pathol; 2015 Oct; 43(7):915-34. PubMed ID: 25722122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity and Immune Complex Disease in Preclinical Safety Studies.
    Vahle JL
    Toxicol Pathol; 2018 Dec; 46(8):1013-1019. PubMed ID: 30157708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxicology testing in drug discovery and development.
    Dorato MA; Buckley LA
    Curr Protoc Toxicol; 2007 Feb; Chapter 19():Unit19.1. PubMed ID: 23045141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The minipig as nonrodent species in toxicology--where are we now?
    Ganderup NC; Harvey W; Mortensen JT; Harrouk W
    Int J Toxicol; 2012; 31(6):507-28. PubMed ID: 23134714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Issues related to the use of canines in toxicologic pathology--issues with pharmacokinetics and metabolism.
    Tibbitts J
    Toxicol Pathol; 2003; 31 Suppl():17-24. PubMed ID: 12597427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Informed toxicity assessment in drug discovery: systems-based toxicology.
    Mayne JT; Ku WW; Kennedy SP
    Curr Opin Drug Discov Devel; 2006 Jan; 9(1):75-83. PubMed ID: 16445119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternatives to Monkey Reproductive Toxicology Testing for Biotherapeutics.
    Hoberman AM; Maki K; Mikashima F; Naota M; Wange RL; Lansita JA; Weis SL
    Int J Toxicol; 2023 Dec; 42(6):467-479. PubMed ID: 37714565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility of human trials to assess developmental immunotoxicity, and some comparison with data on New World monkeys.
    Neubert RT; Webb JR; Neubert D
    Hum Exp Toxicol; 2002; 21(9-10):543-67. PubMed ID: 12458914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.